Welcome to our dedicated page for Tabula Rasa Heal news (Ticker: TRHC), a resource for investors and traders seeking the latest updates and insights on Tabula Rasa Heal stock.
Tabula Rasa HealthCare, Inc. (TRHC) generates news that reflects its focus on medication safety, pharmacy services and technology-enabled solutions for value-based care organizations. Company announcements highlight how TRHC works with health plans, at-risk provider groups and programs such as the Program of All-Inclusive Care for the Elderly (PACE) to address medication-related risks and support complex patient populations.
News coverage for TRHC often includes financial results and operational updates. Earnings releases describe trends in medication revenue and technology-enabled solutions revenue, with commentary on factors such as PACE census growth, revenue per PACE participant and changes in gross margin. These updates also discuss non-GAAP measures like adjusted EBITDA, adjusted gross profit and adjusted operating income or loss, which TRHC presents as supplemental indicators of performance.
Another key category of TRHC news involves strategic and corporate developments. The company has reported the divestiture of non-core businesses such as SinfoníaRx and DoseMe, and it announced a definitive agreement to be acquired by Nautic Partners and combined with ExactCare Pharmacy. Corporate updates have also covered leadership changes, including the appointment of a new President and Chief Executive Officer and the addition of a Chief Legal Officer and Corporate Secretary.
TRHC also issues news about client relationships and solution deployments. For example, the company announced that Mountain Empire PACE signed agreements for personalized pharmacy services and pharmacy benefit management, building on existing use of PACElogic integrated technology solutions and PeakTPA administration services. Such stories illustrate how TRHC’s offerings are applied in real-world care settings.
Investors, analysts and healthcare professionals can use this news stream to follow TRHC’s financial performance, corporate actions, partnerships and the evolution of its medication safety and pharmacy care solutions over time.
Rittenhouse Ventures, a venture capital firm specializing in early-stage software investments, has announced the successful closing of Fund III. The firm now manages over $75M in assets and focuses on capital-efficient B2B software, AI, and tech-enabled services companies.
The fund has already made initial investments in four portfolio companies: GoMo Health, Pieces Technologies, WealthHub Solutions, and High QA. Notable past investments include Tabula Rasa HealthCare (NASDAQ: TRHC) and AppsFlyer. The firm has strengthened its leadership with two new partners: David Nevas, former Partner at Edison Partners, and Sushma Rajagopalan, former CEO of ITC Infotech.
Rittenhouse targets companies with $2M-$10M in revenue, typically investing in rounds of $5M or less, with a particular focus on the Mid-Atlantic region and underserved markets.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Tabula Rasa HealthCare (TRHC) has scheduled a conference call and webcast for May 9, 2023, at 8:30 a.m. EDT to discuss its first quarter 2023 financial results. The financial results will be released after market close on May 8, 2023. TRHC focuses on medication safety solutions, utilizing proprietary technology like MedWise® to optimize medication regimens, minimize adverse drug events, and reduce healthcare costs. Their clinical tele-pharmacy network enhances patient care nationwide, and their services are trusted by health plans and at-risk provider groups for value-based care initiatives.
Tabula Rasa HealthCare (TRHC) has appointed Brian Adams as President and Chief Executive Officer, effective immediately. Adams, who was previously interim CEO, will also join the Board of Directors. Richard W. Rew II has been named Chief Legal Officer and Corporate Secretary, effective April 10, 2023. The company announced preliminary unaudited revenue for Q1 2023, expected to be between $87.0 million and $88.5 million, exceeding prior guidance of $82 million to $84 million. The company plans to report full financial results in early May. The new leadership aims to advance solutions for the Program of All-Inclusive Care for the Elderly (PACE) market and improve patient care.
Tabula Rasa HealthCare (TRHC) reported a strong fourth quarter for 2022, achieving $82.7 million in revenue, a 20% increase year-over-year. Despite this growth, the company recorded a GAAP net loss of $18.4 million, up from $13.0 million the previous year. Full-year revenue reached $299.5 million, a 15% increase, but the net loss grew to $77.3 million. The company has made strategic moves, including leadership changes and the divestiture of non-core businesses, to focus on sustainable growth. Looking ahead, TRHC projects revenue for 2023 to be between $343 million and $354 million, with adjusted EBITDA guidance of $17 million to $20 million.
